Literature DB >> 14521905

Functional interplay between modulation of histone deacetylase activity and its regulatory role in G2-M transition.

Eun Joo Noh1, Jong-Soo Lee.   

Abstract

The acetylation status of histones plays an essential role in regulating transcription and replication, and is thus involved in the proliferation and differentiation of normal and neoplastic cells. Here, we investigated the effect of trichostatin A (TSA), an inhibitor of histone deacetylases (HDACs), on G2-M transition during the cell cycle. HDAC inhibition by TSA arrested the cell cycle at G2 and also induced escape from the mitotic arrest into G1. TSA reduced the expression of cyclin B1, a key cyclin for G2-M transition, but stimulated expression of p21(WAF1/Cip1), an inhibitor of CDK and Cdc2. In contrast, the expression of cyclin B1 but not p21(WAF1/Cip1) is enhanced during M. Moreover, histone acetylation at promoters of these two genes was regulated by TSA. TSA augmented acetylation of the p21(WAF1/Cip1) promoter but reduced that of the cyclin B1 promoter, suggesting the relationship between TSA-induced modulation of histone acetylation and differential expression of these genes. Taken together, our observations suggest that modulation of HDAC activity is implicated in the G2-M transition by regulating the transcription of cell cycle regulators, p21(WAF1/Cip1) and cyclin B1, via modulating acetylation status of the histones at their promoters.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14521905     DOI: 10.1016/j.bbrc.2003.09.013

Source DB:  PubMed          Journal:  Biochem Biophys Res Commun        ISSN: 0006-291X            Impact factor:   3.575


  17 in total

1.  Metastasis-associated protein 3 (MTA3) regulates G2/M progression in proliferating mouse granulosa cells.

Authors:  Jakub Kwintkiewicz; Elizabeth Padilla-Banks; Wendy N Jefferson; Ilana M Jacobs; Paul A Wade; Carmen J Williams
Journal:  Biol Reprod       Date:  2012-03-08       Impact factor: 4.285

2.  Low-dose valproic acid enhances radiosensitivity of prostate cancer through acetylated p53-dependent modulation of mitochondrial membrane potential and apoptosis.

Authors:  Xufeng Chen; Jeffrey Y C Wong; Patty Wong; Eric H Radany
Journal:  Mol Cancer Res       Date:  2011-02-08       Impact factor: 5.852

3.  ATM modulates transcription in response to histone deacetylase inhibition as part of its DNA damage response.

Authors:  Eun Ryoung Jang; Jae Duk Choi; Mi Ae Park; Gajin Jeong; Hyeseong Cho; Jong-Soo Lee
Journal:  Exp Mol Med       Date:  2010-03-31       Impact factor: 8.718

4.  Histone deacetylase inhibitor MS-275 alone or combined with bortezomib or sorafenib exhibits strong antiproliferative action in human cholangiocarcinoma cells.

Authors:  Viola Baradari; Michael Höpfner; Alexander Huether; Detlef Schuppan; Hans Scherübl
Journal:  World J Gastroenterol       Date:  2007-09-07       Impact factor: 5.742

5.  Histone Deacetylase 10 Regulates the Cell Cycle G2/M Phase Transition via a Novel Let-7-HMGA2-Cyclin A2 Pathway.

Authors:  Yixuan Li; Lirong Peng; Edward Seto
Journal:  Mol Cell Biol       Date:  2015-08-03       Impact factor: 4.272

6.  Activation of ATM-dependent DNA damage signal pathway by a histone deacetylase inhibitor, trichostatin A.

Authors:  Jong-Soo Lee
Journal:  Cancer Res Treat       Date:  2007-09-30       Impact factor: 4.679

7.  Functional link between DNA damage responses and transcriptional regulation by ATM in response to a histone deacetylase inhibitor TSA.

Authors:  Jong-Soo Lee
Journal:  Cancer Res Treat       Date:  2007-09-30       Impact factor: 4.679

Review 8.  Histone deacetylase inhibitors: current status and overview of recent clinical trials.

Authors:  Xujun Ma; Hany H Ezzeldin; Robert B Diasio
Journal:  Drugs       Date:  2009-10-01       Impact factor: 9.546

Review 9.  Histone deacetylases: target enzymes for cancer therapy.

Authors:  Denis Mottet; Vincent Castronovo
Journal:  Clin Exp Metastasis       Date:  2007-12-05       Impact factor: 5.150

10.  Acute sensitization of colon cancer cells to inflammatory cytokines by prophase arrest.

Authors:  Anton Kuratnik; Virginia E Senapati; Rajeev Verma; Barbara G Mellone; Anthony T Vella; Charles Giardina
Journal:  Biochem Pharmacol       Date:  2012-01-25       Impact factor: 5.858

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.